Enter assignee name

Trademarks = 1

Forward Citations = 103

Loading Chart...

6 inventors (with patents filed for the assignee):

Stan Gronthos (9 out of 20 patents)

Andrew Zannettino (7 out of 12 patents)

Paul J Simmons (6 out of 10 patents)

4. Andrew Christopher William Zannettino (2 out of 5 patents)

5. Songtao Shi (1 out of 15 patents)

6. John Paul Simmons (1 out of 2 patents)

9 patents: Sort by Forward Citations

1. 9815896 - Monoclonal antibody STRO-4 (2017-11-14),

2. 9783617 - Isolation of adult multipotential cells by tissue non-specific alkaline phosphatase (2017-10-10),

3. 8546138 - Mesenchymal precursor cell (2013-10-01),

4. 8158118 - Mesenchymal precursor cell (2012-04-17),

5. 8062675 - Mesenchymal precursor cell (2011-11-22),

6. 7947266 - Perivascular mesenchymal precursor cells (2011-05-24),

7. 7670628 - Mesenchymal precursor cell (2010-03-02),

8. 7399632 - Mesenchymal precursor cell (2008-07-15),

9. 7122178 - Mesenchymal precursor cell (2006-10-17),

Angioblast Systems, Inc. is a biotechnology company focused on developing innovative stem cell therapies for cardiovascular diseases. Our proprietary technology platform allows us to create therapeutic cell products that have the potential to regenerate damaged heart tissue and improve patient outcomes. With a deep commitment to scientific excellence and patient care, Angioblast aims to revolutionize the treatment of heart disease.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

9 Patents

#695 in NEW YORK, NY

#1,797 in New York

#31,582 in US

NEW YORK, NY, United States of America

Angioblast Systems, Inc.